Research Paper Volume 11, Issue 23 pp 10883—10901
Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer
Figure 2. Survival analysis of breast cancer with high and low CD204 expression statuses among untreated patients, including all cases of breast cancer (A–C), luminal A (D–F), luminal B (G–I), HER2-positive (J, K), and basal-like (L–N) subtype.